PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New super vaccine tested in kids to fight more pneumonia strains
⭐️ VACCINE ⭐️ CompletedThis study tested a new 24-strain pneumococcal vaccine (PCV24) in 119 healthy children aged 2-17 years to see if it is safe and triggers a strong immune response. It was an early-phase trial comparing the new vaccine against an existing 13-strain vaccine in younger children. The …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
New shot for kids tested against leading brand
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of a new version of a 13-valent pneumococcal vaccine in young children. It involved 140 healthy Chinese children, split into two age groups: infants starting at 2 months and children aged 2 to 5 years. The new vaccine was directly …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Research and Development Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:33 UTC